πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7148323

Major neutralization site of hepatitis E virus and use of this neutralization site in meth

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7148036

DNA molecules encoding cartilage-derived morphogenetic proteins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7144986

Polypeptides comprising IL-6 ligand binding receptor domains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7144918

Biologically active macrolides, compositions, and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141234

Imaging of drug accumulation as a guide to antitumor therapy

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141661

Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141589

Methods of inhibiting formation of vascular channels and methods of inhibiting proliferati

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7135303

Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7132420

Aspartic protease inhibitors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7132392

Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7132102

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7129052

Peptides and their utility in modulation of behavior of cells expressing Ξ±3Ξ²1 integrins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7129342

Infectious cDNA clone of GB virus B and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7129332

Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7125553

Methods of inducing immune tolerance using immunotoxins

The United States of America as represented by the Department of Health and Human Services c/o Centers for Disease Control and Prevention Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122624

Parathyroid hormone receptor ligands

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7118758

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7118738

Recombinant pox virus for immunization against MUC1 tumor-associated antigen

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7115262

Chimeric protein for prevention and treatment of HIV infection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7112332

Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysac

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7109245

Vasoconstrictor cannabinoid analogs

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7108981

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7109323

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7109380

Cyclopentenedione antifungal compounds and methods for their use

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted